{{Rsnum
|rsid=5761170
|Gene=MYO18B
|Chromosome=22
|position=25777694
|Orientation=plus
|ReferenceAllele=T
|MissenseAllele=C
|GMAF=0.08356
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
|Gene_s=MYO18B
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 94.6 | 5.4 | 0.0
| HCB | 72.6 | 23.0 | 4.4
| JPT | 81.1 | 16.2 | 2.7
| YRI | 88.3 | 11.0 | 0.7
| ASW | 87.7 | 12.3 | 0.0
| CHB | 72.6 | 23.0 | 4.4
| CHD | 67.6 | 32.4 | 0.0
| GIH | 82.5 | 17.5 | 0.0
| LWK | 86.9 | 12.1 | 0.9
| MEX | 98.2 | 1.8 | 0.0
| MKK | 87.1 | 11.6 | 1.3
| TSI | 97.1 | 2.9 | 0.0
| HapMapRevision=28
}}

{{Venter SNP
|rsid=5761170
|allele=C
|frequency=0.983
|uid=1103691019318
|type=homozygous_SNP
|hugo=MYO18B
|ensembl gene=ENSG00000133454
|ensembl transcript=ENST00000335473
|sift=TOLERATED
|disease=Defects in MYO18B are associated with lung cancer. Inactivated in half of the primary lung cancers and cell lines; the causes include deletions, mutations and promoter methylation.
}}

{{GET Evidence
|gene=MYO18B
|aa_change=Trp661Arg
|aa_change_short=W661R
|impact=not reviewed
|qualified_impact=Insufficiently evaluated not reviewed
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs5761170
|overall_frequency_n=10037
|overall_frequency_d=10324
|overall_frequency=0.972201
|n_genomes=51
|n_genomes_annotated=0
|n_haplomes=98
|n_articles=0
|n_articles_annotated=0
|nblosum100=7
|autoscore=0
|webscore=N
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}